Compounds > terbium
Page last updated: 2024-08-22

terbium and Ovarian Neoplasms

terbium has been researched along with Ovarian Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cohrs, S; Dorrer, H; Fischer, E; Grünberg, J; Köster, U; Lindenblatt, D; Schibli, R; Türler, A; Zhernosekov, K1
Andrews, PA; Canada, RG; Haider, A; Mack, KM1
Canada, RG; Paltoo, DN1

Other Studies

3 other study(ies) available for terbium and Ovarian Neoplasms

ArticleYear
Anti-L1CAM radioimmunotherapy is more effective with the radiolanthanide terbium-161 compared to lutetium-177 in an ovarian cancer model.
    European journal of nuclear medicine and molecular imaging, 2014, Volume: 41, Issue:10

    Topics: Animals; Antibodies, Monoclonal; Cell Line, Tumor; Female; Humans; Lutetium; Mice; Neural Cell Adhesion Molecule L1; Ovarian Neoplasms; Radioimmunotherapy; Radioisotopes; Terbium; Tissue Distribution; Tomography, Emission-Computed, Single-Photon

2014
The effects of terbium on the accumulation of cisplatin in human ovarian cancer cells.
    Biochimica et biophysica acta, 1995, May-29, Volume: 1267, Issue:1

    Topics: Binding Sites; Cell Line; Cisplatin; Dose-Response Relationship, Drug; Drug Resistance; Female; Humans; Ovarian Neoplasms; Receptors, Cell Surface; Terbium

1995
Binding of terbium and cisplatin to C13* human ovarian cancer cells using time-resolved terbium luminescence.
    Biochimica et biophysica acta, 1998, Nov-19, Volume: 1448, Issue:1

    Topics: Antineoplastic Agents; Binding Sites; Biological Transport; Cisplatin; Drug Interactions; Drug Resistance; Female; Humans; Luminescent Measurements; Models, Theoretical; Ovarian Neoplasms; Spectrometry, Fluorescence; Terbium

1998